Does LEUPROLIDE Cause Injection site induration? 207 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Injection site induration have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.3% of all adverse event reports for LEUPROLIDE.
207
Reports of Injection site induration with LEUPROLIDE
0.3%
of all LEUPROLIDE reports
7
Deaths
31
Hospitalizations
How Dangerous Is Injection site induration From LEUPROLIDE?
Of the 207 reports, 7 (3.4%) resulted in death, 31 (15.0%) required hospitalization.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
IXEKIZUMAB (177)
HYDROXYPROGESTERONE CAPROATE (158)
Which LEUPROLIDE Alternatives Have Lower Injection site induration Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM